Stock Market News

2 weeks Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?Investor's Business Daily

Amgen stock rebounded Wednesday, shaking off “overdone” fears that its monthly weight-loss shot causes excessive bone mineral density loss.
The post Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? appeared first on Inv…

Amgen (AMGN) · Eli Lilly (LLY)

12 hours Eli Lilly: Steep Pullback, Still Compelling HereSeeking Alpha X

12 hours Eli Lilly: Steep Pullback, Still Compelling HereSeeking Alpha X

14 hours Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?The Motley Fool X

14 hours Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?The Motley Fool X

2 days Why Amgen (AMGN) is a Top Value Stock for the Long-TermZacks X

2 days RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?Investor's Business Daily X

2 days Goldman Sachs: Eli Lilly and Company (LLY) Is A Top Growth Investor StockInsider Monkey X

2 days Eli Lilly Stock: Unexpected Developments (Rating Downgrade)Seeking Alpha X

3 days Is Now a Good Time to Buy the Dip in Eli Lilly Stock?The Motley Fool X

3 days Is Now a Good Time to Buy the Dip in Eli Lilly Stock?Yahoo Finance X

3 days Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired DropYahoo Finance X

3 days Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’Insider Monkey X

3 days UnitedHealth, Eli Lilly Lead Market Cap Stock Movers on WednesdayInvesting.com X

4 days Is It Time to Sell Eli Lilly and Pfizer Stocks?The Motley Fool X

4 days Is It Time to Sell Eli Lilly and Pfizer Stocks?Yahoo Finance X

4 days The Zacks Analyst Blog Highlights Eli Lilly, PepsiCo and Morgan StanleyZacks X

4 days Top Research Reports for Eli Lilly, PepsiCo & Morgan StanleyZacks X

4 days LLY Oral Cholesterol Drug Lowers Lipoprotein Levels in Phase II StudyZacks X

5 days Here’s Why Eli Lilly and Company (LLY) is on Detractors’ List of Madison Sustainable Equity FundInsider Monkey X

5 days Makers of Weight-Loss Drugs Want Your Employer to Pay for ThemThe Wall Street Journal X

5 days Amgen Sells Off: Keep Calm And Buy The DipSeeking Alpha X

6 days Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowZacks X

6 days Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on ItZacks X

6 days Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-203024/7 Wall St. X

6 days 3 Growth Stocks You Can Buy Right Now Without Any HesitationThe Motley Fool X

7 days Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand?The Wall Street Journal X

1 week 2 Reasons to Buy Amgen Stock, and 1 Reason to Be CautiousThe Motley Fool X

1 week Three-Stock Lunch: Eli Lilly, Transdigm, & NvidiaYouTube X

1 week Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcareFXStreet X

1 week Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting ProgramYahoo Finance X

1 week Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?The Motley Fool X

1 week Amgen Shrugs Off Bone Density Concerns Related to Obesity CandidateZacks X

1 week Is Eli Lilly Stock A Sell After Kennedy-Tied Woes Rankled Shares?Investor's Business Daily X

1 week Is AstraZeneca a Buy as It Eyes the Weight Loss Market?The Motley Fool X

1 week 2 Top Growth Stocks to Buy on the DipThe Motley Fool X

1 week Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript)Seeking Alpha X

1 week Trade Tracker: Joe Terranova sells Amgen and buys XBIYouTube X

2 weeks Did Viking Therapeutics Just Say “Checkmate” To Eli Lilly?The Motley Fool X

2 weeks Amgen dismisses bone density concerns related to its new weight-loss drugInvesting.com X

2 weeks Amgen sinks as Cantor flags issues with obesity drugYouTube X

2 weeks Amgen stock falls as analysts mull over weight loss drug’s bone density dataCNBC X

2 weeks Amgen Drops 7% After A ‘Big Unknown Risk’ Rattles Its Monthly Obesity ShotInvestor's Business Daily X

2 weeks Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?Zacks X

2 weeks Eli Lilly and Company (LLY): Ken Fisher’s Bet on a Pharma Giant’s Growth PotentialInsider Monkey X

2 weeks 1 Stubborn Cloud and 2 Silver Linings for Eli Lilly StockThe Motley Fool X

2 weeks Eli Lilly and Company (LLY): Among the Best Low Volatility Stocks to Invest In NowInsider Monkey X

2 weeks Micron tops list of 20 biggest winners in the S&P 500 this earnings seasonMarketWatch X

2 weeks Eli Lilly Just Hit a Milestone That Disappointed. Here’s Why You Should Still Buy the Stock.The Motley Fool X

2 weeks What Makes Eli Lilly & Co (LLY) a Prospective Investment?Insider Monkey X

2 weeks Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried?The Motley Fool X